KENNESAW, GA (August 2, 2021) – Deerland Probiotics & Enzymes has announced the publication of a new study that is the first of its kind to directly investigate the germination of a spore-forming probiotic strain in the human small intestines. The study, entitled Presence and germination of the probiotic Bacillus subtilis DE111® in the human small intestinal tract, has been published in Frontiers in Microbiology.
Deerland Probiotics & Enzymes has announced that its proprietary strain of Bacillus subtilis DE111 has been granted non-Novel Food ingredient status in Canada.…More
DE111 Probiotic Provides Benefits for Body Fat Percentage and Athletic Performance, According to Latest Study
Researchers have found that consumption of the probiotic strain DE111 in conjunction with adequate post-workout nutrition can improve body composition…More
Wouldn’t it be great if you could capitalize on more people wanting hot drinks and more people wanting probiotics to…More